Circulating Tumor Cells Clinical Trial
Official title:
Culture of Circulating Tumor Cells Isolated From Cancer Patients With Metastatic Disease
The purpose of this study is to investigate the feasibility of using novel decellularized tissue matrices to isolate and culture circulating tumor cells (CTCs) collected from patients with metastatic solid tumor malignancies.
There are currently very few practical or reproducible model systems which recapitulate the metastatic process well. CTCs are important for the development of metastases and there is interest in isolating and culturing them ex vivo to better characterize their biology, metastatic potential, and response to different therapies. The investigators have previously demonstrated efficient capture and enumeration of CTCs in 4 unique patient cohorts (metastatic prostate and locally advanced rectal, cervical and head and neck cancers) in the investigators prospective clinical study, LCCC 1408 (Investigation of Circulating Tumor Cells from Cancer Patients Undergoing Radiation Therapy). However, CTCs are difficult to culture with conventional methods. The investigators propose to culture CTCs using novel decellularized tissue matrices. Blood will be collected from cancer patients with metastatic solid tissue tumors prior to starting definitive or palliative radiotherapy. The investigators will then isolate CTCs and attempt to grow them on various decellularized matrices. If this study is successful and feasibility is demonstrated, important pilot information will also be gathered which will then be used in power and sample size considerations for future CTCs studies. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02072616 -
Detection of Circulating Tumor Cells for the Diagnostic of Pancreatic Adenocarcinoma.
|
Phase 3 | |
Completed |
NCT02808884 -
Cancer DNA Screening Pilot Study (CANDACE)
|
N/A | |
Recruiting |
NCT06068348 -
Liquid Biopsy Collection Study
|
||
Completed |
NCT02335151 -
CTC Pancreatic Adenocarcinoma
|
Phase 4 | |
Completed |
NCT01015625 -
Primary Operation in SYnchronous meTastasized InVasivE Breast Cancer
|
N/A | |
Recruiting |
NCT02602938 -
Aspirin on CTCs of Advanced Breast and Colorectal Cancer
|
Phase 2 | |
Completed |
NCT02499458 -
Prospective Validation of Circulating Tumor Cells & Circulating Endothelial Cells as Biomarkers in Renal Cancer
|
||
Completed |
NCT03101046 -
Treatment of Metastatic Castrate Resistant Prostate Cancer Patients According to Circulating Tumor Cells Kinetic
|
Phase 2 | |
Completed |
NCT02449837 -
Investigation of Circulating Tumor Cells From Cancer Patients Undergoing Radiation Therapy
|
||
Recruiting |
NCT02451384 -
According CTC to Compare the Influences of Different Methods to Remove the PDAC
|
N/A | |
Recruiting |
NCT01052818 -
Therapeutic and Prognostic Impact of Circulating Tumor Cells in Peripheral Blood in Patients With Non Small-cell Lung Cancer
|
N/A | |
Not yet recruiting |
NCT04239105 -
Detection of Circulating Tumor Cells in Breast Cancer Patients Using a Novel Microfluidic and Raman Spectrum Device
|
||
Recruiting |
NCT02554448 -
Detection of CTCs in Stage III Rectal Cancer Patients Undergoing Neoadjuvant Therapy
|
N/A | |
Recruiting |
NCT03156777 -
Application Value of CTCs Detection for Advanced Gastric Cancer Patients
|
N/A | |
Completed |
NCT02345473 -
Detection and Clinical Significance of Circulating Cancer Cells in Patient Undergoing Radical Cystectomy
|
N/A | |
Not yet recruiting |
NCT04229121 -
Clinical Sensitivity Verification Study of Circulating Tumor Cells Gene Mutation Detection From Advanced NSCLC Patients
|
||
Completed |
NCT02955173 -
Significance of Circulating Tumor Cells in the Treatment of Gastric and Rectal Cancer
|
N/A | |
Completed |
NCT03340844 -
Role of CTC´s Spread During Pancreaticoduodenectomy in Patients With Pancreatic and Periampullary Tumors
|
N/A | |
Active, not recruiting |
NCT03381326 -
CTC, Free DNA, Stem Cells and EMT-related Antigens as Biomarkers of Activity of Cabazitaxel in CRPC.
|
||
Completed |
NCT05502458 -
Effect of Propofol and Desflurane on Nucleic Acid of Liver Circulating Tumor
|
Phase 2 |